Linda F. Fried, MD, MPH, FASN, Councilor

Linda Fried, MD, MPH, FASN, is Professor of Medicine, Epidemiology, and Clinical & Translational Science at the University of Pittsburgh and a Staff Physician at the VA Pittsburgh Healthcare System.
She earned her medical degree from the Mount Sinai School of Medicine in New York and completed an internal medicine residency at Columbia Presbyterian Medical Center, followed by a fellowship in nephrology at the University of Pittsburgh Medical Center. She also holds a Master of Public Health degree from the University of Pittsburgh.
Dr. Fried's research interests focus on the progression of and risk factors for chronic kidney disease and how they pertain to mortality and cardiovascular disease and aging-related outcomes in CKD. She is active in both epidemiologic studies and clinical trials, especially for diabetic kidney disease. She chaired the VA NEPHRON D study, which assessed combination ACEI and ARB therapy in diabetic kidney disease. She is part of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Study, as co-PI of the coordinating center. This study aims to reduce adverse outcomes and CKD in patients discharged from hospital after AKI.
Highly active as a committee member and advisor, Dr. Fried has served on the FDA Cardiovascular and Renal Drug Advisory Committee and several expert panels for the National Institute of Diabetes and Digestive and Kidney Diseases. She is currently an ASN Councilor
Current Position/Titles:
Degrees/Training:
ASN Service:
- 2020: Co-chair, Education Committee (Program Committee merged with Post-graduate Education Committee)
- 2019: Member Education committee
- 2017: Course Director, Diabetes Precourse
- 2016-2018: Post-Graduate Education Committee
- 2015: Member, Program Committee
- Abstract Selection Committee Member, multiple years
- 2014: Chair, Abstract Selection Committee for CKD: Epidemiology, Outcomes
Leadership positions:
FDA Cardiovascular and Renal Drug Advisory Committee 2013-2016; Associate Editor CJASN 2011-2016; Associate Editor JASN 2021 NIDDK Observational Study Monitoring Board, CRIC, 2012-2020 (Chair 2018-2020), NIDDK Observational Study Monitoring Board, USRDS, 2019-present (Chair), NIDDK Observational Study Monitoring Board, CKiD, 2018-present VA/DoD 2025 Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease Guideline Work Group (VA Champion)
Honors:
Alpha Omega Alpha Honor Medical Society; National Kidney Foundation Serving the Alleghenies Gift of Life Medical Award 2012; NKF Shaul Massry Distinguished Lecture 2016; VA Pittsburgh Healthcare System Office of Research and Development award, 2018, University of Pittsburgh Renal Electrolyte Division Award for Clinical Excellence, 2023
Board Certification:
Nephrology, Internal Medicine
Research Interests:
My research interests focus on progression of and risk factors for chronic kidney disease and how they pertain to: mortality, disease progression, cardiovascular disease and aging-related outcomes in CKD. I am active in both epidemiologic studies and clinical trials. I currently serve as co-PI of the Pittsburgh Coordinating Center of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Study. This study aims to reduce adverse outcomes and CKD in patients discharged from hospital after AKI. More recently, I have been involved in implementation programs to increase utilization of medications to slow progression of kidney disease (RAS, SGLT2i, GLP1Ra, nsMRAs).
Personal Statement:
As a clinician and researcher, it is an exciting time to be a nephrologist. We have entered a new era with multiple treatments that improve outcomes for our patients. In order to maintain this momentum, we need to advocate for research funding for nephrology. In addition, we need to overcome barriers that limit access to new therapies to all patients at risk. I want to share my enthusiasm with the community at large with mentoring, collaboration and fostering access to quality care. I am committed to the ASN’s goals of fostering career development, research and equitable care for patients.